A total of @ breakthrough pain patients with bone metastases were randomly divided to @ groups : group A ( pregabalin combined with intrathecal sufentanil infusion group , n = @ ) , group B ( placebo combined with intrathecal sufentanil infusion group , n = @ ) and group C ( oral morphine sulfate controlled-release tablet group , n = @ ) .